Langaware

Market position

Positioning emphasizes speed (a screening process completed in just over three minutes), reported accuracy validated against expert-provided ground truth labels, and accessibility — testing described as unbiased, education-independent and deployable in any setting, whether self-administered, in person or remote, in contrast to instruments such as PHQ-9 scoring, which the company's blog critiques.

Technology

The platform is built on speech analysis and proprietary voice and speech digital biomarkers, applying AI to language, speech and voice patterns extracted from a short recorded audio sample. Model training uses ground-truth labels provided by medical experts. The company reports 90% sensitivity and 85% specificity for dementia and 83% sensitivity and 80% specificity for depression, and describes the test as education-independent and administrable by self-service, in person or remotely.

Go-to-market

The website drives demand through demo requests and a self-service "Take The Test" entry point, with segment-specific pages for providers, payors, life sciences and corporate wellness. A blog ("Mind Matters") and newsletter are used for content marketing, and testimonials from clinicians, including the chief medical officer of American TelePhysicians and a practicing physician, are featured as references.

Four customer segments are addressed: healthcare providers (reduced time-to-diagnosis and more timely specialist referral with fewer resources), payors (early-priority referral of high-risk patients, cost savings and support for risk adjustment measures), life sciences companies (clinical trial participant recruitment and evaluation of participant response trends), and corporate wellness programs (employee health initiatives, reduced absenteeism and improved engagement).